Trade Pfizer PFE

Sell
 Buy

PFIZER live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

PFIZER news

Latest news

Show more
2025 Oct 31, 00:00

LME to Permanently Restrict Large Positions Amidst Low Inventory

2025 Oct 22, 10:04

The Future of Payments: Fragmentation, Digital Assets, and AI

2025 Oct 22, 07:21

Daily Market Review and Trend Analysis: October 22

2025 Oct 22, 07:20

Crypto Cities: Challenges and Opportunities for a Decentralized Future

2025 Oct 22, 07:20

OpenAI's Atlas Browser: A Glimpse into the Future of AI Agents on the Web

2025 Oct 22, 00:00

Precious Metals Retreat Amid Easing Trade Tensions and Rate Cut Expectations

2025 Oct 22, 00:00

Australian Gold Rush: Record Prices Spark Queues and Investment Debate

Finance Magnates Africa Summit 2023
Shaun Edwards 2023 Apr 10, 02:10

Join markets.com and Bryan Habana at Finance Magnates Africa Summit 2023!

Info

Spread

0.19

Spread (%)

0.6709 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

161927725056

Shares Outstanding

5699673589

Earnings Date (Next)

2020-11-17

Div Yield

2026-09-01

Ex-Dividend Date

2026-07-24

Forward annual dividend rate

1.72

Forward annual dividend yield

0.061

EPS

0.77

Learn more about this instrument

Pfizer Pfizer Inc
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

latest_education_articles

Show more
Trustpilot